Alicja Januszewicz
Director/Miembro de la Junta en Women In The Enterprise of Science & Technology .
Cargos activos de Alicja Januszewicz
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Director/Miembro de la Junta | - | - |
Historial de carrera de Alicja Januszewicz
Antiguos cargos conocidos de Alicja Januszewicz.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 16/12/2021 | 01/11/2022 |
BAXTER INTERNATIONAL INC. | Oficial de Recursos Humanos | 01/08/2015 | 01/11/2016 |
EPIZYME, INC. | Corporate Officer/Principal | 01/01/2007 | 01/01/2013 |
ALLENA PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 01/01/2019 | - |
Formación de Alicja Januszewicz.
Kenan-Flagler Business School | Undergraduate Degree |
Polish Academy of Sciences | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Polonia | 2 |
Operativa
Human Resources Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ALLENA PHARMACEUTICALS, INC. | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Commercial Services |
- Bolsa de valores
- Insiders
- Alicja Januszewicz
- Experiencia